Nanomedicine: Drugs can be made ‘smarter’ using new drug design technology

A new method has been developed to make drugs ‘smarter’ using nanotechnology so they will be more effective at reaching their target

picture of

Breaking News

Avacta announces successful outcome of gene delivery collaboration

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits

BIA Separations and Biomay collaborate on production and purification of large DNA plasmids

The collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application

Sartorius and Penn State Uni announce partnership

Collaborative partnership to advance multidisciplinary teaching and research in biotechnology

Riding the wave of protein revolution

Optimised biocatalysts for the pharmaceutical and food industries

GE accelerates production of viral vector based therapeutics

GE Healthcare has launched a new factory-in-a-box, designed to accelerate the manufacture of products requiring a ...

Merck introduces single-use technologies to advance flexible manufacturing

The innovations, all designed to make single-use bioprocessing easier, safer and more efficient, were unveiled at ...

Performance validation: HPAPI containment testing in a risk-based era

Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, ...

Wacker strengthens its pharmaceutical-protein business and buys Dutch biotech plant

Wacker Chemie AG has acquired a Dutch site to manufacture biopharmaceuticals, live microbial products and vaccines, ...

Sartorius Stedim Biotech and Penn State University announce partnership

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance ...

Biopharma boom brings benefits to CROs

The analytical outsourcing sector is well placed to benefit from the continuing rise in biopharmaceutical manufacturing

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Gene transfer therapy approved for the treatment of ALL: part II

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Almac Diagnostics validates Illumina TruSight Tumor 170 cancer mutation panel clinical trials

The Almac Illumina TruSight Tumor 170 Clinical Trial Assay is a Next Generation Sequencing (NGS) assay for use with ...

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Agreement strengthens Orchard’s position as a global leader in gene therapy for rare diseases